Scarica l'app Stockscreener
11.62
9.64%
-1.24
Ars Pharmaceuticals Inc Borsa (SPRY) Ultime notizie
ARS Pharmaceuticals Inc. recovery potential after sell off2025 Market Sentiment & Smart Investment Allocation Tips - Newser
Using data models to predict ARS Pharmaceuticals Inc. stock movement2025 Stock Rankings & Weekly Breakout Stock Alerts - Newser
Real time social sentiment graph for ARS Pharmaceuticals Inc.Insider Selling & Expert-Curated Trade Recommendations - Newser
Ars Pharmaceuticals Reports Strong Q2 Growth and Global Expansion - TipRanks
What recovery options are there for ARS Pharmaceuticals Inc.July 2025 Review & Safe Capital Investment Plans - Newser
How to monitor ARS Pharmaceuticals Inc. with trend dashboardsQuarterly Profit Report & Free Technical Confirmation Trade Alerts - Newser
Analyzing ARS Pharmaceuticals Inc. with multi timeframe charts2025 Trading Volume Trends & Real-Time Market Sentiment Alerts - Newser
How to interpret RSI for ARS Pharmaceuticals Inc. stockWeekly Risk Report & AI Powered Market Entry Strategies - Newser
Custom watchlist performance reports with ARS Pharmaceuticals Inc.2025 Major Catalysts & Fast Exit and Entry Strategy Plans - Newser
Comparing ARS Pharmaceuticals Inc. in custom built stock radarsEarnings Overview Summary & Consistent Growth Stock Picks - Newser
What MACD and RSI say about ARS Pharmaceuticals Inc.July 2025 Analyst Calls & Safe Capital Allocation Plans - Newser
Quantitative breakdown of ARS Pharmaceuticals Inc. recent moveMarket Volume Report & Capital Efficient Trading Techniques - Newser
Ranking ARS Pharmaceuticals Inc. among high performing stocks via toolsQuarterly Growth Report & Free Reliable Trade Execution Plans - Newser
Technical analysis overview for ARS Pharmaceuticals Inc. stock - Newser
What machine learning models say about ARS Pharmaceuticals Inc.Market Weekly Review & Daily Stock Trend Watchlist - Newser
Real time pattern detection on ARS Pharmaceuticals Inc. stockIPO Watch & Weekly Chart Analysis and Trade Guides - Newser
Risk vs reward if holding onto ARS Pharmaceuticals Inc.Volume Spike & Daily Volume Surge Signals - Newser
ARS Pharma drops 9% as Lupin files application for generic neffy - MSN
Is ARS Pharmaceuticals Inc. forming a bottoming baseLayoff News & Daily Growth Stock Investment Tips - Newser
What machine learning models say about ARS Pharmaceuticals Inc2025 Performance Recap & AI Powered Buy and Sell Recommendations - Newser
How hedge fund analytics apply to ARS Pharmaceuticals Inc. stockSwing Trade & Proven Capital Preservation Tips - Newser
How high can ARS Pharmaceuticals Inc. stock goSell Signal & Daily Volume Surge Trade Alerts - Newser
Advanced analytics toolkit walkthrough for ARS Pharmaceuticals Inc.2025 Analyst Calls & AI Driven Price Predictions - Newser
Price momentum metrics for ARS Pharmaceuticals Inc. explained2025 Support & Resistance & High Yield Stock Recommendations - Newser
Can ARS Pharmaceuticals Inc. rally from current levelsAnalyst Upgrade & Verified Swing Trading Watchlists - Newser
Custom watchlist performance reports with ARS Pharmaceuticals IncProfit Target & Daily Technical Forecast Reports - Newser
ARS Pharmaceuticals Faces Wider Loss in Q2, Stirring Market Concerns - StocksToTrade
Trading Bots Trigger Alerts on ARS Pharmaceuticals Inc. Activity getLinesFromResByArray error: size == 0 - thegnnews.com
ARS Pharmaceuticals Down 9% as Lupin Files Generic Neffy Application - AInvest
What the charts say about ARS Pharmaceuticals Inc. today2025 Biggest Moves & AI Driven Stock Reports - Newser
0.96%
1.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):